Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Skin: early-phase trial registry
3 of 6 indexed Skin trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Skin: 6 US clinical trials tracked, 3 recruiting.
Skin is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is LycoRed, running 2 of these trials.
Enrollment posture brief
Registry condition skin
OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Skin lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Skin on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Skin is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Skin research.
LycoRed accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Skin trials plan to enrol fewer than 100 people.
Median target enrolment is 66 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Skin research is mostly interventional.
5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
Efforia
NCT07298382
Trial of Ixazomib for Kaposi Sarcoma
AIDS Malignancy Consortium
NCT04305691
In Vivo Cross-Modal Imaging of Skin
Gabriel Sanchez
NCT07188948
Lumenato Nutritional Supplement on Skin Appearance
LycoRed
NCT04248699
A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
LycoRed
NCT05537350
The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
University of California, Davis
NCT05011461
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Skin records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Skin trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Skin page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Skin trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- LycoRed sponsors the most Skin trials on record, review their full trial history before evaluating a specific study. See LycoRed's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Skin condition card totals 6 registered trials; most-linked intervention Lumenato; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.